JM

John Michael Carvalho

Active Director Director DIN 10590182
DIN 10590182 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About John Michael Carvalho

Data last updated:

John Michael Carvalho is a Director at Zdenka Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10590182
Primary Designation Director
Industry Paper
First Appointment 12 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Apr 20242024Active

Board colleagues of John Michael Carvalho

NameDINCompanyDesignation
Febian Manvel Dias10590183Zdenka Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zdenka Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for John Michael Carvalho

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Michael Carvalho

John Michael Carvalho currently holds 1 directorship: Zdenka Pharmaceuticals Private Limited (Director, since 12 Apr 2024).

John Michael Carvalho was first appointed on 12 Apr 2024 as Director at Zdenka Pharmaceuticals Private Limited.

The current boards of John Michael Carvalho's companies include Febian Manvel Dias (Zdenka Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available